Medication Abortion Mifepristone Medical Ethics Abortion Pill Medical Abortion Medication Abortion Drugs Access Legislation Medication Abortions Health Risks Abortion Restrictions Healthcare Access Abortion Pills Physician Training Chemical Abortion Drugs Chemical Abortions Abortion Bans Planned Parenthood South Carolina Physicians In-Office Procedures Legalization Access to Healthcare Access to Care Legal Restrictions Medical Risks Legal Aspects Abortion Activists Clinic Abortion Drug Mifepristone Abortion Drug Abortion Policy Mifepristone and Misoprostol Post-Abortion Syndrome Self-Managed Abortion Medical Care Medical Necessity Support Systems Maternal Mortality
The findings give abortion‑pill critics new leverage to press the FDA to restore in‑person safeguards.
